MedTrace Logo

Triple P forADHD Children's Mothers, Education of Behavioral Problems, and Change in Mothers' Attitude

NCT07069621 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2026-01-29

Study results available
· View outcomes & findings →

Summary

The goal of this clinical trial is to investigate whether the Triple P program will reduce behavioral problems for ADHD children, improve mothers' sense of competency, and improve their attitudes

The main questions it aims to answer are:

1 . What is the feasibility and cultural acceptability of implementing the Triple P program within the Palestinian context? 2. Does the Triple P program promote positive attitudes towards managing ADHD among mothers in Palestine? 3. How does the Triple P program affect the maternal sense of competency among mothers in Palestine? 4. Does the Triple P program delivery affect reducing children's ADHD behavioural symptoms?

Participants :

took the triple p strategies, and the control will not Outcome measures will be evaluated pre- and post-intervention

Conditions

  • ADHD, Predominantly Hyperactive - Impulsive
  • Behavior Problems, Child
  • ADHD - Attention Deficit Disorder With Hyperactivity
  • Healthy Adult Females
  • Competence
  • Positive Parenting

Interventions

BEHAVIORAL

Triple p level parenting program

An evidence-based program with self-agency strategies enhances trust and confidence in managing children's ADHD behaviors

Sponsors & Collaborators

  • Palestine Polytechnic University

    lead OTHER

Principal Investigators

  • Nadia A Amro, phd · AAUP

  • Nadia A Amro, phd · Palestine Polytechnic University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-25
Primary Completion
2024-08-30
Completion
2024-08-30

Countries

  • Palestinian Territories

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07069621 on ClinicalTrials.gov